Pharmacyclics, Inc. (NASDAQ:PCYC)

CAPS Rating: 1 out of 5

A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.

Recs

0
Player Avatar Photoncatcher00 (< 20) Submitted: 6/24/2012 11:04:48 PM : Outperform Start Price: $0.00 PCYC Score: 0

Continued uptrend for 3 months with tremendous % increases.

Featured Broker Partners


Advertisement